Stocks making the biggest moves midday: Oracle, Bath & Body Works, Gap and more

Risk-off flows driven by AI-valuation worries and a slide in bitcoin (near $80,000) weighed on markets midday, knocking Oracle about 4% lower and dragging bitcoin-linked miners (American Bitcoin -8%, Riot -2%, Galaxy Digital -5%) down. Company-specific moves were mixed: Bath & Body Works fell another ~5% (adding to a 24.8% plunge) after a Q3 miss and analyst downgrades, Azenta rallied >10% on fiscal Q4 beats (adj. EPS $0.21 vs. $0.19; revenue $159.2m vs. $156.2m), QuidelOrtho jumped 11% after an insider purchase, and Enviri surged ~29% after agreeing to sell its Clean Energy unit to Veolia for $3.04bn and spinning off other divisions. Elastic and Veeva slumped (Elastic -14% on slowing cloud growth; Veeva -11% as it warned of fewer top biopharma adopters of Vault CRM) while Gap and Ross outperformed on stronger same-store sales and revenue beats; biotech AnaptysBio edged lower amid a lawsuit over its Jemperli license.

Analysis

Market internals are tilted toward risk-off flows driven by AI valuation concerns and a sharp move lower in bitcoin toward $80,000; Oracle declined about 4% midday and AI-linked names including Nvidia saw steep weekly losses while bitcoin miners such as American Bitcoin (-8%), Riot (-2%) and Galaxy Digital (-5%) fell as investors fled risk assets. This macro risk-off amplified volatility across sectors despite mixed corporate results. Company-specific earnings produced divergent stock reactions that emphasize execution and guidance over headline beats. Azenta jumped over 10% after fiscal Q4 results topped expectations (adj. EPS $0.21 vs. $0.19; revenue $159.2m vs. $156.2m) while Elastic tumbled 14% despite beating estimates because of decelerating cloud growth; Veeva fell 11% despite EPS $2.04 vs. $1.95 as it warned of fewer top biopharma Vault CRM wins. Corporate actions and signal events are creating idiosyncratic opportunities: Enviri rallied ~29% after agreeing to sell Clean Energy to Veolia for $3.04bn and planning a spin-off (close mid-2026), QuidelOrtho rose 11% on a 23,500-share insider purchase, and Bath & Body Works dropped a further ~5% after a Q3 miss and downgrades from Morgan Stanley and Goldman Sachs. These moves imply a bifurcated market where earnings quality, guidance and M&A catalysts drive performance more than headline beats.

Key Decisions for Investors

• Trim or hedge exposure to AI-valuation sensitive names (e.g., ORCL, NVDA) until clarity on revenue/cost cadence reduces multiple compression
• Favor idiosyncratic, execution-led winners like Azenta and retail names with clear same-store sales momentum (Gap, Ross) but monitor upcoming guidance revisions closely
• Evaluate Enviri as an event-driven play ahead of the $3.04bn Clean Energy sale and mid-2026 close, performing due diligence on pro forma balance sheet and spin-off mechanics
• Reduce or hedge positions in bitcoin-linked miners and crypto treasuries given the bitcoin pullback toward $80k and elevated downside volatility
• Use insider buys (QuidelOrtho) and analyst downgrades (Bath & Body Works) as timely signals to add or exit positions, and avoid relying solely on headline beats when guidance or customer adoption trends are negative